Olema Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Olema Pharmaceuticals

08/08/2023 23:02

* Olema Pharmaceuticals Inc  OLMA.OQ  reported a quarterly
adjusted loss of 49 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 73 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Olema Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 49 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Olema Pharmaceuticals Inc shares had risen by 1.8% this
quarter and gained 275.1% so far this year.
    * The company reported a quarterly loss of $20.1 million.
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 10:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.73          -0.49          Beat
 Mar. 31 2023      -0.66          -0.70          Missed
 Dec. 31 2022      -0.65          -0.65          Met
 Sep. 30 2022      -0.77          -0.57          Beat